Harvard Bioscience to Attend Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum

Bitget2026/11/04 12:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Harvard Bioscience will attend Canaccord Genuity's MedTech, Diagnostics, and Digital Health and Services Forum on Nov. 11, 2026.
CEO John Duke and CFO Mark Frost will participate in one-on-one meetings.
Duke will present on the “Emerging Tools for Research and Biopharma Use Cases” panel at 9:30 a.m. ET.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Bioscience Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611040730PRIMZONEFULLFEED9869671) on November 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Harvard Bioscience to Attend Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum

You may also like

Crypto prices